Glaucoma News

St. Louis - Chances are you've never heard of Mobius in St. Louis or Synergetics in O'Fallon, Missouri.

Altheos Inc. raised an additional $12.5 million - pushing its Series A round to a total of $32.5 million - as the South San Francisco company enters a mid-stage study of a glaucoma drug.

ST. LOUIS, Feb. 9, 2012 /PRNewswire/ -- Mobius Therapeutics , LLC , a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform product, Mitosol .

Grand Challenges Canada today announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions.

From Paracelsus Medical University, in Salzburg, Austria, comes a report of the three-year postoperative safety and efficacy outcomes of the Acufocus corneal inlay .

It is indicated in the treatment of the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.

Judy and Earl Rudloff felt fine, and their vision seemed as good as it always had.

Glaucoma is one of the leading causes of blindness. Millions of Americans are living with the condition, and many more may not know they have it.

A $1.85 million NIH grant will support a study to determine the effectiveness of adaptive optics in capturing the earliest cellular changes signaling the onset of glaucoma, which may lead to earlier diagnosis of the blinding disease.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia WATERTOWN, Mass.-- --pSivida Corp.

Pharmaceutical giant Pfizer has hit a legal wall in its bid to block the production of a generic eye drug after the Supreme Court of Canada declined Thursday to hear the company's appeal.

Bernard Batey and Lydia Besong, of Kestrel Drive, had been booked seats on flights from Heathrow Airport to Cameroon, via Paris, on Saturday morning.

Glaucoma has no warning signs so many people do not realize they have it, increasing the need for early detection, a U.S. ophthalmologist said.

Glaucoma is one of the leading causes of blindness. Millions of Americans are living with the condition, and many more may not know they have it.

Jason Porter, assistant professor of vision science and biomedical engineering at the University of Houston, stands in front of the AOSLO device he built.

Bernard Batey and Lydia Besong, of Kestrel Drive, had been booked seats on flights from Heathrow Airport to Cameroon, via Paris, on Saturday morning.

Glaucoma is the leading cause of irreversible blindness, yet it attacks silently, with no symptoms.

Millions of Americans are living with the condition, and many more may not know they have it.

A lot of eyesight medical practitioners address people who go to their office environment moaning of ailments including attention stress, head suffering, and difficulty with vision.

Research to Prevent Blindness has awarded Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, a $30,000 Medical Student Eye Research Fellowship.